(Q82865636)

English

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective

scientific article published on 10 February 2010

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

title

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

author name string

J D Campbell

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

S D Sullivan

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

publication date

10 February 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

volume

65

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

page(s)

1141-1148

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

Identifiers

DOI

10.1111/J.1398-9995.2010.02336.X

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

retrieved

18 January 2020

PubMed publication ID

20148804

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20148804

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20148804%20AND%20SRC:MED&resulttype=core&format=json

(Q82865636)

The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)